3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
1
Colonic Neoplasms
1
Agnosia
1
Abdominal Pain
1
Interventions
Bupivacaine
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
parecoxib
2
Surveys and Questionnaires
2
Ropivacaine
2
Morphine
2
Lidocaine
2
Hydromorphone
2
Anesthesia, Local
2
Analgesia, Patient-Controlled
2
Analgesia, Epidural
2
oxycodone-acetaminophen
1
Transcranial Magnetic Stimulation
1
Transcranial Direct Current Stimulation
1
Tramadol
1
Tea
1
Surgical Instruments
1
Saline Solution
1
Rehabilitation
1
Orphenadrine
1
Methadone
1
Ketorolac Tromethamine
1
Ketorolac
1
Ketamine
1
Hydrocodone
1
Gabapentin
1
Fentanyl
1
Ethanol
1
Drug Therapy
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Bulk Drugs
×
Gastrointestinal
×
Clear all
NCT04311099
2025-08-07
OPMICS
Nordsjaellands Hospital
Phase 4
Completed
360 enrolled